Ausgabe 1/2025
Inhalt (15 Artikel)
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
- Review Article
David J. Benjamin, Alain C. Mita
IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for Chondrosarcoma
- Review Article
Shriya Deshmukh, Ciara Kelly, Gabriel Tinoco
Unveiling the Digital Evolution of Molecular Tumor Boards
- Open Access
- Review Article
Sebastian Lutz, Alicia D’Angelo, Sonja Hammerl, Maximilian Schmutz, Rainer Claus, Nina M. Fischer, Frank Kramer, Zaynab Hammoud
Delayed Separation of Kaplan–Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis
- Open Access
- Systematic Review
Do-Youn Oh, Nana Rokutanda, Magdalena Żotkiewicz, Philip He, Jennifer Stocks, Melissa L. Johnson
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis
- Systematic Review
Takafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, Tatsushi Kawada, Satoshi Katayama, Ekaterina Laukhtina, Pawel Rajwa, Fahad Quhal, Benjamin Pradere, Wataru Fukuokaya, Kosuke Iwatani, Luca Afferi, Gautier Marcq, Laura S. Mertens, Andrea Gallioli, Karl H. Tully, Jorge Caño-Velasco, José Daniel Subiela, Yasmin Abu-Ghanem, Elisabeth Grobet-Jeandin, Francesco Del Giudice, Renate Pichler, Jeremy Yuen-Chun Teoh, Marco Moschini, Wojciech Krajewski, Jun Miki, Shahrokh F. Shariat, Takahiro Kimura
Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies
- Systematic Review
Hui-Chen Su, Ho-Wei Lin, Ka-Wai Tam
Risk and Benefit for Basket Trials in Oncology: A Systematic Review and Meta-Analysis
- Open Access
- Systematic Review
Katarzyna Klas, Karolina Strzebonska, Lucja Zaborowska, Tomasz Krawczyk, Alicja Włodarczyk, Urszula Bąk-Kuchejda, Maciej Polak, Simon Van Wambeke, Marcin Waligora
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials
- Systematic Review
Chiara Ciccarese, Matteo Bauckneht, Luca Zagaria, Giuseppe Fornarini, Viria Beccia, Francesco Lanfranchi, Germano Perotti, Giada Pinterpe, Fortuna Migliaccio, Giampaolo Tortora, Lucia Leccisotti, Gianmario Sambuceti, Alessandro Giordano, Orazio Caffo, Roberto Iacovelli
Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial
- Original Research Article
Hua Xu, Xin Yao, Zhisong He, Hong Luo, Guiling Li, Jianming Guo, Lei Diao, Yu Fan, Yuan Li, Jiquan Fan, Xiaoyi Hu, Puhan Lu, Haiyan Shi, Keyan Chen, Panfeng Tan, Songhua Fan, Michael Shi, Weiguo Su, Dingwei Ye
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors
- Open Access
- Original Research Article
Manish R. Patel, Gerald S. Falchook, Judy S. Wang, Esteban Rodrigo Imedio, Sanjeev Kumar, Kowser Miah, Ganesh M. Mugundu, Suzanne F. Jones, David R. Spigel, Erika P. Hamilton
Post-Metastasis Survival of Patients with High-Risk Localized and Locally Advanced Prostate Cancer Undergoing Primary Treatment in the United States: A Retrospective Study
- Open Access
- Original Research Article
Stephen J. Freedland, Luis Fernandes, Francesco De Solda, Nasuh Buyukkaramikli, Suneel D. Mundle, Sharon A. McCarthy, Daniel Labson, Lingfeng Yang, Feng Pan, Carmen Mir
Durvalumab Following Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Differences in Survival Based on Age and Post-Progression Systemic Therapy
- Original Research Article
Doran Ksienski, Pauline T. Truong, Jeffrey N. Bone, Sarah Egli, Melissa Clarkson, Tiffany Patterson, Mary Lesperance, Suganija Lakkunarajah
Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study
- Original Research Article
Hiroshi Doi, Yukinori Matsuo, Noriko Kishi, Masakazu Ogura, Takamasa Mitsuyoshi, Nami Ueki, Kazuhito Ueki, Kota Fujii, Masato Sakamoto, Tomoko Atsuta, Tomohiro Katagiri, Takashi Sakamoto, Masaru Narabayashi, Shuji Ohtsu, Satsuki Fujishiro, Takahiro Kishi, Takashi Mizowaki
Immunotherapy Following Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients with Anaplastic Lymphoma Kinase‑Positive Non‑small Cell Lung Cancer in Japan
- Original Research Article
Yuki Shimomura, Megumi Mizutani, Hisako Yoshida, Yasutaka Ihara, Ayumi Shintani
Correction: Ivosidenib: A Review in Advanced Cholangiocarcinoma
- Open Access
- Correction
James E. Frampton
